San Diego – March 10, 2017 – Cooley advised the underwriters on Dermira’s $193.8 million shelf-takedown offering of 5,750,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares.
Leerink Partners, Evercore ISI and Guggenheim Securities acted as joint book-running managers for the offering. Needham & Company acted as co-manager.
Dermira, which trades on The NASDAQ Global Select Market as “DERM,” is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.